Structure-based design of novel Lassa virus glycoproteins for vaccine development
用于疫苗开发的新型拉沙病毒糖蛋白的基于结构的设计
基本信息
- 批准号:10438220
- 负责人:
- 金额:$ 14.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-14 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AchievementAdoptedAfricaAfricanAnimal ModelAntibodiesArenavirusCaviaCell membraneClinical TrialsCollaborationsCommunicable DiseasesComplexCrystallizationDevelopmentEbolaEbola VaccinesEbola virusEbola virus envelope glycoproteinEpitopesEuropeEvaluationFamilyGP2 geneGTPBP1 geneGeographyGlycoproteinsGoalsGovernmentHIVHumanImmune responseImmunologyIndustryInfectionInjectionsLassa FeverLassa virusMacaca fascicularisMemory B-LymphocyteMonkeysNigeriaNorth AmericaPersonsProductionPublic HealthReagentRecombinantsRodentRole ConceptsStructureSurfaceSurvivorsTechnologyTestingTherapeuticTimeUniversitiesVaccine DesignVaccinesValidationVesicular stomatitis Indiana virusViral Hemorrhagic FeversViral Load resultVirionVirusVirus-Cell Membrane Interactionbasecross reactivitydesignhuman monoclonal antibodiesimmunogenicimmunogenicitymonomermultidisciplinaryneutralizing monoclonal antibodiesnonhuman primatenovelporcine modelpreclinical evaluationprogramsresponsescale upstructural biologysuccessvaccine candidatevaccine developmentvaccine efficacyweapons
项目摘要
“Structure-based design of novel Lassa virus glycoproteins for vaccine development”
ABSTRACT
Lassa fever is an often-fatal viral hemorrhagic fever (VHF) that is endemic in West Africa, and a significant
threat to public health with hundreds of thousands of annual infections. There are no approved vaccines or
therapeutics for human use. The potential for further geographic expansion of the rodent reservoirs, the ease
of procurement and weaponization of the virus, the frequent importation to North America and Europe, and
the recent emergence of novel strains in densely populated Nigeria necessitate development of broadly
reactive, fast-acting, protective vaccines. We recently determined the structure of the LASV glycoprotein
trimer in complex with neutralizing monoclonal antibodies (MAbs) derived from Lassa fever survivors. This
ground-breaking structure is the first prefusion trimer for the entire arenavirus family. This application will test
the hypothesis that this newly determined structure can guide design of novel LASV glycoproteins that
rapidly elicit broadly protective immune responses against current, antigenically diverse virus lineages. We
will now use this novel crystal structure as a design template for further stabilization of native trimers for
vaccine development. The proposed project will build on the success of a promising recombinant vesicular
stomatitis virus (rVSV) Ebola platform already in West African Ebola clinical trials. In studies proposed under
Milestone 1, we will produce a set of genetically modified, structurally stable LASV GPC constructs that
mimic native prefusion trimers and effectively present broadly neutralizing epitopes. We will construct,
validate and scale up a replication-competent, single-injection bivalent or trivalent rVSV vaccine candidate
expressing optimized LASV GPC and EBOV GP in Milestone 2. The aim of Milestone 3 is to down-select
LASV GPC constructs that elicit broad and rapid immunogenicity and superior vaccine efficacy in an outbred
guinea pig model of lethal Lassa fever. In Milestone 4, we will demonstrate that the most effective LASV
GPC-expressing vaccine candidate elicits protection against diverse lineages of LASV in cynomolgus
macaques. At the conclusion of the proposed program we will enter pre-clinical evaluation of a first-in-class
bivalent vaccine for Lassa virus and Ebola virus, the causative agents of two of the world's deadliest
hemorrhagic fevers.
This application contains proprietary/priviledged information that Tulane University and its subcontractors
request not be released to persons outside the Government, except for the purposes of review and
evaluations.
用于疫苗开发的新型拉萨病毒糖蛋白的结构设计
摘要
拉沙热是一种经常致命的病毒性出血热(VHF),在西非流行,并且有显著的
每年有数十万人感染,对公共卫生构成威胁。没有批准的疫苗或
供人类使用的治疗学。啮齿动物水库在地理上进一步扩张的潜力,
病毒的采购和武器化,经常进口到北美和欧洲,以及
最近在人口稠密的尼日利亚出现了新的菌株,因此有必要发展广泛的
反应性、快效性、保护性疫苗。我们最近确定了LASV糖蛋白的结构
三聚体与来自拉沙热幸存者的中和单抗(MAb)形成复合体。这
突破性结构是整个禽流感病毒家族的第一个灌流三聚体。此应用程序将测试
这种新确定的结构可以指导设计新的LASV糖蛋白的假设
快速诱导针对当前抗原性多样化的病毒谱系的广泛保护性免疫反应。我们
现在将使用这种新的晶体结构作为进一步稳定天然三聚体的设计模板
疫苗研发。拟议的项目将建立在前景看好的重组泡囊的成功基础上。
口炎病毒(RVSV)埃博拉平台已经在西非进行埃博拉临床试验。在以下建议的研究中
里程碑1,我们将生产一组转基因的、结构稳定的LASV GPC构建物
模拟天然的灌流三聚体,有效地呈现广泛的中和表位。我们将建造,
验证并扩大复制能力的单次注射二价或三价rVSV候选疫苗
在里程碑2中表达优化的LASV GPC和EBOV gp。里程碑3的目的是向下选择
LASV GPC构建可在近交系中广泛而快速地诱导免疫原性和卓越的疫苗效力
致死性拉沙热豚鼠模型。在里程碑4中,我们将展示最有效的LASV
表达GPC的疫苗候选疫苗对食蟹LASV不同谱系的保护作用
猕猴。在提议的项目结束时,我们将进入一流的临床前评估
拉萨病毒和埃博拉病毒的双价疫苗,这两种病毒是世界上最致命的两种病毒的病原体
出血热。
此应用程序包含杜兰大学及其分包商的专有/特权信息
请求不得向政府以外的人发布,除非是为了审查和
评估。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert F Garry其他文献
Erratum to: Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report
- DOI:
10.1186/1743-422x-8-480 - 发表时间:
2011-10-25 - 期刊:
- 影响因子:3.800
- 作者:
Luis M Branco;Matt L Boisen;Kristian G Andersen;Jessica N Grove;Lina M Moses;Ivana J Muncy;Lee A Henderson;John S Schieffellin;James E Robinson;James J Bangura;Donald S Grant;Vanessa N Raabe;balu M Fonnie;Eleina M Zaitsev;Pardis C Sabeti;Robert F Garry - 通讯作者:
Robert F Garry
RETRACTED ARTICLE: Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in Hepatitis C virus replicon
- DOI:
10.1186/1743-422x-4-89 - 发表时间:
2007-09-18 - 期刊:
- 影响因子:3.800
- 作者:
Sidhartha Hazari;Lizeth Taylor;Salima Haque;Robert F Garry;Sander Florman;Ronald Luftig;Frederic Regenstein;Srikanta Dash - 通讯作者:
Srikanta Dash
RETRACTED ARTICLE: Small interfering RNA targeted to stem-loop II of the 5' untranslated region effectively inhibits expression of six HCV genotypes
- DOI:
10.1186/1743-422x-3-100 - 发表时间:
2006-11-27 - 期刊:
- 影响因子:3.800
- 作者:
Ramesh Prabhu;Robert F Garry;Srikanta Dash - 通讯作者:
Srikanta Dash
Proteomics computational analyses suggest that the bornavirus glycoprotein is a class III viral fusion protein (γ penetrene)
- DOI:
10.1186/1743-422x-6-145 - 发表时间:
2009-09-18 - 期刊:
- 影响因子:3.800
- 作者:
Courtney E Garry;Robert F Garry - 通讯作者:
Robert F Garry
An invitation to recent graduates: publish your dissertation/thesis background section as a review in Virology Journal
- DOI:
10.1186/1743-422x-4-46 - 发表时间:
2007-06-02 - 期刊:
- 影响因子:3.800
- 作者:
Robert F Garry - 通讯作者:
Robert F Garry
Robert F Garry的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert F Garry', 18)}}的其他基金
Preclinical Evaluation of Advanced Pan-Lassa Immunotherapeutic Cocktails
先进的泛拉沙免疫治疗混合物的临床前评估
- 批准号:
10158449 - 财政年份:2019
- 资助金额:
$ 14.37万 - 项目类别:
Preclinical Evaluation of Advanced Pan-Lassa Immunotherapeutic Cocktails
先进的泛拉沙免疫治疗混合物的临床前评估
- 批准号:
10402339 - 财政年份:2019
- 资助金额:
$ 14.37万 - 项目类别:
Preclinical Evaluation of Advanced Pan-Lassa Immunotherapeutic Cocktails
先进的泛拉沙免疫治疗混合物的临床前评估
- 批准号:
10617738 - 财政年份:2019
- 资助金额:
$ 14.37万 - 项目类别:
Systems-level identification of host determinants of patient outcomes in Lassa fever and Ebola
拉沙热和埃博拉患者预后的宿主决定因素的系统级识别
- 批准号:
10374719 - 财政年份:2018
- 资助金额:
$ 14.37万 - 项目类别:
Systems-level identification of host determinants of patient outcomes in Lassa fever and Ebola
拉沙热和埃博拉患者预后的宿主决定因素的系统级识别
- 批准号:
10310605 - 财政年份:2018
- 资助金额:
$ 14.37万 - 项目类别:
Systems-level identification of host determinants of patient outcomes in Lassa fever and Ebola
拉沙热和埃博拉患者预后的宿主决定因素的系统级识别
- 批准号:
10579086 - 财政年份:2018
- 资助金额:
$ 14.37万 - 项目类别:
Structure-based design of novel Lassa virus glycoproteins for vaccine development
用于疫苗开发的新型拉沙病毒糖蛋白的基于结构的设计
- 批准号:
10202410 - 财政年份:2017
- 资助金额:
$ 14.37万 - 项目类别:
Preclinical evaluation of a potent Lassa fever immunotherapeutic antibody cocktail
有效的拉沙热免疫治疗抗体混合物的临床前评估
- 批准号:
9926211 - 财政年份:2017
- 资助金额:
$ 14.37万 - 项目类别:
Preclinical evaluation of a potent Lassa fever immunotherapeutic antibody cocktail
有效的拉沙热免疫治疗抗体混合物的临床前评估
- 批准号:
10176382 - 财政年份:2017
- 资助金额:
$ 14.37万 - 项目类别:
相似海外基金
How novices write code: discovering best practices and how they can be adopted
新手如何编写代码:发现最佳实践以及如何采用它们
- 批准号:
2315783 - 财政年份:2023
- 资助金额:
$ 14.37万 - 项目类别:
Standard Grant
One or Several Mothers: The Adopted Child as Critical and Clinical Subject
一位或多位母亲:收养的孩子作为关键和临床对象
- 批准号:
2719534 - 财政年份:2022
- 资助金额:
$ 14.37万 - 项目类别:
Studentship
A material investigation of the ceramic shards excavated from the Omuro Ninsei kiln site: Production techniques adopted by Nonomura Ninsei.
对大室仁清窑遗址出土的陶瓷碎片进行材质调查:野野村仁清采用的生产技术。
- 批准号:
20K01113 - 财政年份:2020
- 资助金额:
$ 14.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A comparative study of disabled children and their adopted maternal figures in French and English Romantic Literature
英法浪漫主义文学中残疾儿童及其收养母亲形象的比较研究
- 批准号:
2633211 - 财政年份:2020
- 资助金额:
$ 14.37万 - 项目类别:
Studentship
A comparative study of disabled children and their adopted maternal figures in French and English Romantic Literature
英法浪漫主义文学中残疾儿童及其收养母亲形象的比较研究
- 批准号:
2436895 - 财政年份:2020
- 资助金额:
$ 14.37万 - 项目类别:
Studentship
A comparative study of disabled children and their adopted maternal figures in French and English Romantic Literature
英法浪漫主义文学中残疾儿童及其收养母亲形象的比较研究
- 批准号:
2633207 - 财政年份:2020
- 资助金额:
$ 14.37万 - 项目类别:
Studentship
A Study on Mutual Funds Adopted for Individual Defined Contribution Pension Plans
个人设定缴存养老金计划采用共同基金的研究
- 批准号:
19K01745 - 财政年份:2019
- 资助金额:
$ 14.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The limits of development: State structural policy, comparing systems adopted in two European mountain regions (1945-1989)
发展的限制:国家结构政策,比较欧洲两个山区采用的制度(1945-1989)
- 批准号:
426559561 - 财政年份:2019
- 资助金额:
$ 14.37万 - 项目类别:
Research Grants
Securing a Sense of Safety for Adopted Children in Middle Childhood
确保被收养儿童的中期安全感
- 批准号:
2236701 - 财政年份:2019
- 资助金额:
$ 14.37万 - 项目类别:
Studentship
Structural and functional analyses of a bacterial protein translocation domain that has adopted diverse pathogenic effector functions within host cells
对宿主细胞内采用多种致病效应功能的细菌蛋白易位结构域进行结构和功能分析
- 批准号:
415543446 - 财政年份:2019
- 资助金额:
$ 14.37万 - 项目类别:
Research Fellowships